|
Marketing problems of your
products
As for the global launch new
products, to get as much as possible market share in the
shortest time, more resource are allocated, it is expected
to be detailed to many specialties with as high as possible
call frequency.
As for the matured products, it
is important to maintain focused noise to selected segments
and screening out new segments to penetrate.
Companies spend a lot on the
promotion of new treatment guideline, it is important to
track if and in what extend the therapy regimens are
adopted.
The key issue is to take a
close track for the doctors' prescription on specific
indication, with comfortable control on its sampling error
and measurement error.
There is a high incidence of
diabetes mellitus in China which presents a real threat to
the health of the population. At present, most of the top
pharmaceutical companies have products to treat diabetes
mellitus.
|
|
 |
Do you know
the "end users" of your products, and who |
|
|
prescribes them? |
|
 |
Do you
target the right segment for your product? |
|
 |
What are the
potential segments for your product? |
|
 |
How are new
competitors doing? Who are the prescribers of |
|
|
these competitive products and for which group of patients? |
|
 |
What are the
prescription trends of your products: is there |
|
|
more combination therapy being prescribed, or is there a |
|
|
change in dosage levels? |
|
In order to meet client needs, Shanghai Loudon Marketing
Consultant Co. has developed a syndicated study - Prescription
Tracking which offers our clients a tool to monitor the market
status of their diabetic medicines.
Objectives
The main objectives of the study are to: |
|
 |
Segment diabetic market by patients' profile (diabetes
types, |
|
|
concom-itant conditions), and treatment pattern |
|
|
(mono/combination,
users of specific category hypoglycemic |
|
|
agents, etc.) |
|
 |
Track prescription pattern of doctors (diabetes types;
hospital |
|
|
level,
beds, professional title) and acceptance for new |
|
|
regimens |
|
 |
Define market opportunities by entering into new segments,
f |
|
|
ine tune the usage of products |
|
 |
Bench marketing, establish competitive edges against |
|
|
competitors |
|
 |
Analysis the trends of prescription pattern by category or
|
|
|
product |
|
Methodology
Total 2,200 patients will be recorded in 5 departments of 8 cities. The sample is as follows

5 categories of diabetic medicines have been analyzed including:
|
| |
- |
Insulins |
| |
- |
Sulfaurea drugs |
| |
- |
Biguanide drugs |
| |
- |
Thiazole alkane derivants |
| |
- |
A-glycosidase inhibitor |
|
Detailed patient information has been recorded covering: |
| |
- |
Patients demographics,
including age, gender, weight and |
|
|
height,health
care insurance status, department consulted, |
|
|
lab test parameter if available, e.g. FPG, 2hPPG, HbA1c, |
|
|
etc. |
| |
- |
Medicine prescribed, manufacturers,
presentations, |
|
|
strength,dose, combination or mono therapy. |
|
Key findings of the reports
Market size and profile of patient segments |
| |
- |
By diabetes type |
| |
- |
By healthcare insurance status |
| |
- |
By city |
|
Prescription of categories and products |
| |
-
|
By patient segments |
| |
- |
By doctor segment: |
|
|
department/professionalpositions/hospital level |
|
Doctors' prescription pattern for each patient segment |
| |
-
|
By mono/combination therapy |
| |
- |
By category/product |
| |
- |
By physicians department |
|
Application
As a tracking report, it will identify details of patients demographics, analyse the competitive environment, help to develop competitive positioning strategies for the products, and track the effectiveness of marketing activities for the launch of new products or indications. Following information can be get from the report: |
|
 |
Market Size / patient number of each segment of diabetes |
|
|
mellitus |
|
 |
Patient profile of each segment of diabetes mellitus |
|
 |
Define the market attractiveness and potential of the product in
|
|
|
eachsegment
|
|
 |
Therapy and prescription analysis of each segment |
|
 |
Usage and prescription pattern of diabetes mellitus in each
|
|
|
segment
|
|
If you have additional specific questions about your product we are able to provide tailor made analysis with our methods and the large database available to us. |